This subset was linked to a more pronounced inflammatory profile compared to conventional hepatic CXCR3-Th17 (chTh17) cells and correlated with the severity of MASLD [71]. The gene discussed is CXCR3; the disease is metabolic dysfunction-associated steatotic liver disease.